4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001493152-21-022217
Options or other derivatives
- Chief Business Officer acquired 675,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Saund Saran · Chief Business Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-09-03 | Grant or award : show line 1 in the form Stock Options | +675,000 | 675,000 | D |
Loading xslF345X03/ownership.xml…